Cargando…

IGFBP2 potentiates nuclear EGFR-STAT3 signaling

Insulin-like growth factor binding protein 2 (IGFBP2) is a pleiotropic oncogenic protein that has both extracellular and intracellular functions. Despite a clear causal role in cancer development, the tumor-promoting mechanisms of IGFBP2 are poorly understood. The contributions of intracellular IGFB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chua, Corrine Yingxuan, Liu, Yuexin, Granberg, Kirsi J., Hu, Limei, Haapasalo, Hannu, Annala, Matti J., Cogdell, David E., Verploegen, Maartje, Moore, Lynette M., Fuller, Gregory N., Nykter, Matti, Cavenee, Webster K., Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615268/ https://www.ncbi.nlm.nih.gov/pubmed/25893308 http://dx.doi.org/10.1038/onc.2015.131

Ejemplares similares

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
por: Granberg, Kirsi J, et al.
Publicado: (2017)

Whole-exome sequencing identifies germline mutation in TP53 and ATRX in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytoma
por: Nordfors, Kristiina, et al.
Publicado: (2018)

Erratum: Whole-exome sequencing identifies germline mutation in TP53 and ATRX in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytoma
por: Nordfors, Kristiina, et al.
Publicado: (2018)

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
por: Lehtinen, Birgitta, et al.
Publicado: (2017)

CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity
por: Filppu, Pauliina, et al.
Publicado: (2021)

Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma
por: Li, Xia, et al.
Publicado: (2014)

Modes of immunosuppression in glioblastoma microenvironment
por: Lehtipuro, Suvi, et al.
Publicado: (2019)

Segmentum: a tool for copy number analysis of cancer genomes
por: Afyounian, Ebrahim, et al.
Publicado: (2017)

PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas
por: Rautajoki, Kirsi J., et al.
Publicado: (2022)

A Linear Model for Transcription Factor Binding Affinity Prediction in Protein Binding Microarrays
por: Annala, Matti, et al.
Publicado: (2011)

Early-onset grade 2-3 diffuse gliomas and schwannomas increase the risk of central nervous system tumors among the patients’ relatives
por: Alanen, Eljas, et al.
Publicado: (2023)

Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response
por: Kukkonen, Konsta, et al.
Publicado: (2021)

DOT1L-HES6 fusion drives androgen independent growth in prostate cancer
por: Annala, Matti, et al.
Publicado: (2014)

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer
por: Annala, Matti, et al.
Publicado: (2015)

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
por: Kaukoniemi, Kirsi M, et al.
Publicado: (2015)

Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
por: Rautajoki, Kirsi J., et al.
Publicado: (2023)

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
por: Latonen, Leena, et al.
Publicado: (2018)

Frequent mutation of the FOXA1 untranslated region in prostate cancer
por: Annala, Matti, et al.
Publicado: (2018)

Data-driven characterization of molecular phenotypes across heterogeneous sample collections
por: Mehtonen, Juha, et al.
Publicado: (2019)

The expression of AURKA is androgen regulated in castration-resistant prostate cancer
por: Kivinummi, Kati, et al.
Publicado: (2017)

Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer
por: Taavitsainen, Sinja, et al.
Publicado: (2019)

Prostate‐specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain
por: Tanjore Ramanathan, Jayendrakishore, et al.
Publicado: (2020)

Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma
por: Yang, Jilong, et al.
Publicado: (2014)

Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks
por: Gomez, German G., et al.
Publicado: (2013)

A Drosophila Model for EGFR-Ras and PI3K-Dependent Human Glioma
por: Read, Renee D., et al.
Publicado: (2009)

Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
por: Bova, G. Steven, et al.
Publicado: (2016)

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer
por: Sjöblom, Liisa, et al.
Publicado: (2016)

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
por: Kallio, Heini M. L., et al.
Publicado: (2018)

Proteomics of prostate cancer – revealing how cancer cells master their messy genomes
por: Latonen, Leena, et al.
Publicado: (2018)

Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma
por: Li, Ming, et al.
Publicado: (2011)

Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
por: Cheng, Hanyin, et al.
Publicado: (2011)

Fanconi anemia pathway regulation by FANCI in prostate cancer
por: Kaljunen, Heidi, et al.
Publicado: (2023)

Comparison of iTRAQ and SWATH in a clinical study with multiple time points
por: Jylhä, Antti, et al.
Publicado: (2018)

Balance between Noise and Information Flow Maximizes Set Complexity of Network Dynamics
por: Mäki-Marttunen, Tuomo, et al.
Publicado: (2013)

Leukemia Prediction Using Sparse Logistic Regression
por: Manninen, Tapio, et al.
Publicado: (2013)

EL1 BUILDING A CAREER IN NEURO-ONCOLOGY RESEARCH
por: Cavenee, Webster K
Publicado: (2019)

SL2 ADVANCES IN MOLECULAR BIOLOGY AND GENETICS IN GLIOMA RESEARCH AND THERAPY
por: Cavenee, Webster K
Publicado: (2019)

Early pregnancy serum IGFBP-1 relates to lipid profile in overweight and obese women
por: Mokkala, Kati, et al.
Publicado: (2020)

Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
por: Jin, Li, et al.
Publicado: (2020)

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3
por: Zhao, Lei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5ur118365924t5i4bck4jr2fl2